Diabetes
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Diabetes Publish Ahead of Print published online ahead of print July 23, 2007
DOI: 10.2337/db07-0360

This Article
Right arrow Full Text (PDF)
Right arrow Online-Only Appendix
Right arrow All Versions of this Article:
db07-0360v1
56/10/2541    most recent
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serino, M.
Right arrow Articles by Federici, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serino, M.
Right arrow Articles by Federici, M.
Social Bookmarking
 Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Original Research

TNF-alpha Converting Enzyme heterozygous mice are protected from obesity-induced insulin resistance and diabetes

Matteo Serino1, Rossella Menghini1, Loredana Fiorentino1, Roberta Amoruso1, Alessandro Mauriello2, Davide Lauro1, Paolo Sbraccia1, Marta L. Hribal1, Renato Lauro1, and Massimo Federici1

1Laboratory of Molecular Medicine, Department of Internal Medicine,
2Department of Biopathology, University of Rome "Tor Vergata", Rome, Italy

Correspondence: federicm{at}uniroma2.it

Objective:TNF-{alpha} is known to affect insulin sensitivity, glucose and lipid metabolism through alternative and redundant mechanisms at both translational and post-translational levels. TNF- {alpha} exerts its paracrine effects once the membrane-anchored form is shed and released from the cell membrane. TNF-{alpha} cleavage is regulated by TNF-{alpha} Converting Enzyme (TACE), which regulates the function of several transmembrane proteins, such as Interleukin-6 Receptor (IL-6R) and EGF Receptor ligands. The role of TACE in high fat diet induced obesity and its metabolic complications is unknown.

Research Design and Methods:To gain insights into the role of TACE in metabolic disorders we used Tace+/– mice fed with a standard or high fat diet (HFD) for 16 weeks.

Results:We observed that Tace+/– mice are relatively protected from obesity and insulin resistance compared with WT littermates. When fed a HFD, WT mice exhibited visceral obesity, increased FFA and Monocyte Chemoattractant Protein-1 (MCP1) levels, hypoadiponectinemia, glucose intolerance and insulin resistance compared with Tace+/– mice. Interestingly, Tace+/– mice exhibited increased UCP-1 and GLUT4 expression in white adipose tissue.

Conclusions:our results suggest that modulation of TACE activity is a new pathway to be investigated for development of agents acting against obesity and its metabolic complications.



Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
DiabetesHome page
S. Boullu-Ciocca, V. Achard, V. Tassistro, A. Dutour, and M. Grino
Postnatal Programming of Glucocorticoid Metabolism in Rats Modulates High-Fat Diet-Induced Regulation of Visceral Adipose Tissue Glucocorticoid Exposure and Sensitivity and Adiponectin and Proinflammatory Adipokines Gene Expression in Adulthood
Diabetes, March 1, 2008; 57(3): 669 - 677.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2007 by the American Diabetes Association.